Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

RECOMMENDED

Atopic Dermatitis

Position statement: topical calcineurin inhibitors in atopic dermatitis

doi: 10.1111/jdv.15272.

Atopic Dermatitis

Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis

J Am Acad Dermatol.

Thyssen JP, Toft PB, Halling-Overgaard AS, Gislason GH, Skov L, Egeberg A

doi: 10.1016/j.jaad.2017.03.003.

Autoimmune Disease

Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults

Int J Cancer.

McGee EE, Castro FA, Engels EA, Freedman ND, Pfeiffer RM, Nogueira L, Stolzenberg-Solomon R, McGlynn KA, Hemminki K, Koshiol J

doi: 10.1002/ijc.31835.

Melanoma and Skin Cancer

Sunscreen Use and Melanoma Risk Among Young Australian Adults

JAMA Dermatol.

Watts CG, Drummond M, Goumas C, Schmid H, Armstrong BK, Aitken JF, Jenkins MA, Giles GG, Hopper JL, Mann GJ, Cust AE

doi: 10.1001/jamadermatol.

Atopic Dermatitis

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

Br J Dermatol.

de Bruin-Weller M, Thaçi D, Smith CH, Reich K, Cork MJ, Radin A, Zhang Q, Akinlade B, Gadkari A, Eckert L, Hultsch T, Chen Z, Pirozzi G, Graham NMH6, Shumel B

doi: 10.1111/bjd.16156.

Atopic Dermatitis

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet

Reich K, Teixeira HD, de Bruin-Weller M, Bieber T, Soong W, Kabashima K, Werfel T, Zeng J, Huang X, Hu X, Hendrickson BA, Ladizinski B, Chu AD, Silverberg JI

doi: 10.1016/S0140-6736(21)00589-4

Melanoma and Skin Cancer

Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States

JAMA Dermatol.

D'Arcy ME, Pfeiffer RM, Rivera DR, Hess GP, Cahoon EK, Arron ST, Brownell I, Cowen EW, Israni AK, Triplette MA, Yanik EL, Engels EA

doi: 10.1001/jamadermatol.

Atopic Dermatitis

Risk of systemic infections in adults with atopic dermatitis: a nationwide cohort study

J Am Acad Dermatol.

Droitcourt C, Vittrup I, Kerbrat S, Egeberg A, Thyssen JP

doi: 10.1016/j.jaad.2020.07.111.

Atopic Dermatitis

Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter study

J Eur Acad Dermatol Venereol.

Jachiet M, Nosbaum A, Staumont-Sallé D, Seneschal J, Viguier M, Soria A, Barbaud A, Carriou AC, Chuffart-Delplanque M, Darrigade AS, Fite C, de Masson A, Bagot M, Chevret S, Bouaziz JD

doi: 10.1111/jdv.15774.

Related content

Position statement: topical calcineurin inhibitors in atopic dermatitis

Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis

Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults

Sunscreen Use and Melanoma Risk Among Young Australian Adults

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States

Risk of systemic infections in adults with atopic dermatitis: a nationwide cohort study

Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter study